"Abington Hematology Oncology Associates is an 8 physician practice located in Southeastern Pennsylvania dedicated to providing compassionate and cutting edge cancer care and hematologic treatments to all of our patients. Our offices are conveniently located in Horsham, PA and Philadelphia, PA."

During the past decade, Abington Hematology Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Abington Hematology Oncology" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Neoplasm Metastasis" (1 trials) and "TNBC - Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Abington Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Abington Hematology Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABI-007 (Abraxane)" (1 trials), "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "Placebo" (1 trials) and "Trilaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abington Hematology Oncology" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Abington Hematology Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Abington Hematology Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Abington Hematology Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".